Mesa Laboratories Inc (NASDAQ: MLAB) has reported earnings for its first fiscal quarter (ending June 30) of $0.63 versus a loss $-0.10 for the same period a year ago. E.P.S. were $-46.41 for the latest four quarters through June 30 versus $0.34 for the same period a year ago — a decline of -13750%.
Recent Price Action
On 8/5/24, Mesa Laboratories Inc (NASDAQ: MLAB) stock declined by -2.0%, closing at $104.71. Moreover, this decline was accompanied by above average trading volume at 133% of normal. The stock has performed in line with the market over the last nine months and has declined -4.8% during the last week.
Current PriceTarget Research Rating
MLAB is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Mesa Laboratories has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Mesa Laboratories has a poor Appreciation Score of 15 but a good Power Rating of 70, with the Negative Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment